HIV-1 infection-induced expansion of activated naïve B-cells has been suggested to be viremia-dependent, as elevated frequencies of CD95+ activated naïve B-cells were observed in viremic HIV-1-infected individuals, but not in HIV-1-infected individuals receiving successful ART treatment [59]. This evidence concerns the gene FAS and HIV-1 infection.